Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/2010
07/07/2010CN101766585A Medical paste film
07/07/2010CN101766584A Long-circulating degradable polymer nano microcapsule synergistically modified by polyethylene glycol/water-soluble chitosan and preparation method thereof
07/07/2010CN101766582A Levamlodipine beaylate tablets and preparation method thereof
07/07/2010CN101766579A Duloxetine enteric-coated sustained release preparation as well as core material and preparation method thereof
07/07/2010CN101766578A Tablet containing Rosuvastatin calcium and preparation process thereof
07/07/2010CN101766577A Solid preparation of clopidogrel free alkali and preparation process thereof
07/07/2010CN101766573A Preparation process of clopidogrel bisulfate solid preparation
07/07/2010CN101766571A Cefpiramide, sodium benzoate, sodium bicarbonate pharmaceutical composite lipidosome injection
07/07/2010CN101766570A PH-sensitive precursor cation nanometer liposome of target tumour cell and preparation method thereof
07/07/2010CN101766569A Long-acting antimicrobial medical oil emulsion and preparation method thereof
07/07/2010CN101766564A High-efficiency water-solubility toltrazuril solution and preparation method thereof
07/07/2010CN101766562A Medicine carrying polymer micelle and preparation method thereof
07/07/2010CN101366700B Hydrophilic medicament dual-microsphere formulation and preparation method thereof
07/07/2010CN101229141B Aspirin sustained release tablet and preparing method thereof
07/07/2010CN101147805B Method for preparing magnetic silica medicine-carried microball in cotton seed oil by microemulsion method
07/07/2010CN101138557B Chlorhexidine acetate partial film forming gel composition and uses thereof
07/06/2010US7750136 Using ribosome-inactivating protein (RIP)/cytotoxin fusion to target and destroy tumor cells
07/06/2010US7750114 Peptides having a high cysteine content
07/06/2010US7750052 Separately protonation of alcohol and water; blending; food processing
07/06/2010US7749975 immunomers comprising at least two oligonucleotides linked at their 3' ends by internucleoside linkages, functionalized nucleobase or sugar to a non-nucleotidic linkers, used for treating cancer, autoimmune diseases, airway inflammation, inflammatory or skin disorders, allergy or asthma
07/06/2010US7749970 Application of an azalide antibiotic such as azithromycin
07/06/2010US7749957 Clay-binding peptides and methods of use
07/06/2010US7749954 Use of calcitonin in osteoarthritis
07/06/2010US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators
07/06/2010US7749718 Method for raising or isolating an antibody to DCRS5
07/06/2010US7749540 Compositions comprising modafinil compounds
07/06/2010US7749538 Molded object having high pullulan content, process for the producing the same, and use thereof
07/06/2010US7749534 chemotherapeutical agent comprising cis-diammoniumdichloro-trans-dihydroxoplatinum(IV) or salts and/or derivatives thereof in the form of capsules, tablets, creams, ointments and infusion solutions; antitumor agents
07/06/2010US7749520 cationic liposomes containing alpha, alpha'-trehalose 6,6' dibehenate, ceramide and ganglioside, prepared from bromide salt of dimethyldioctadeceylammonium; drug delivery; immunology, vaccines
07/06/2010US7749513 lowering plasma cholesterol level in a subject by administering a preparation comprising an isolated membrane fraction separated from cytoplasmic material, the membrane fraction made from bacteria of Rhodospirillum spp. and/or Phaeospirillum spp
07/06/2010US7749511 An immunogenic conjugate comprising a plurality of deacylated lipopolysaccharide molecules from a gram-negative bacterium covalently linked to gucosamine residue of D.discodideum proteinase 1
07/06/2010US7749485 Liposomal assembly for therapeutic and/or diagnostic use
07/06/2010US7748388 Endoscopic injectable preparation
07/06/2010US7748377 Methods and systems for operating an aerosol generator
07/06/2010CA2484664C Green porphyrin loaded nanoparticles and their use in photodynamic therapy
07/06/2010CA2461893C Immediate release tablet comprising a powered wax
07/06/2010CA2460222C Eustachian tube stent
07/06/2010CA2367548C Composition containing a precursor capable of being hydrolysed by gluco erebrosidase
07/06/2010CA2338089C Topical compositions comprising moisture regulating wicking fibers
07/06/2010CA2335566C Effervescent drug delivery system for oral administration
07/06/2010CA2333188C Multiparticulate pharmaceutical form with programmed and timed release and preparation method
07/06/2010CA2298864C Chemical modification of proteins to improve biocompatibility and bioactivity
07/06/2010CA2286396C Oligonucleotides for enhanced bioavailability
07/06/2010CA2286091C Polymer-platinum compounds
07/06/2010CA2150785C Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
07/01/2010WO2010075545A1 Method for inducing a trif-bias
07/01/2010WO2010075423A2 Dendrimer based modular platforms
07/01/2010WO2010075060A2 Methods and compositions for modulating proline levels
07/01/2010WO2010075010A2 Oligosaccharide-protein conjugates
07/01/2010WO2010074992A2 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
07/01/2010WO2010074935A1 Synthesis of obtaining modified polyethylene glycol intermediates
07/01/2010WO2010074711A2 Ceramic honeycomb structure skin coating
07/01/2010WO2010074662A1 Antitumor agent, a method for the production of said agent and a method for the stabilisation thereof
07/01/2010WO2010074541A2 Drug delivery carrier using zz domain
07/01/2010WO2010074460A2 Novel pharmaceutical composition for ameliorating side effects of a lipase inhibitor
07/01/2010WO2010074239A1 Microneedle device
07/01/2010WO2010074223A1 Coating material for solid medicine and solid medicine formed with same
07/01/2010WO2010074183A1 Transdermal preparation
07/01/2010WO2010074182A1 Transdermal preparation
07/01/2010WO2010074163A1 Complex and manufacturing method therefor
07/01/2010WO2010074113A1 Dry powder pharmaceutical composition for inhalation
07/01/2010WO2010074082A1 Modified vasohibin
07/01/2010WO2010073642A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
07/01/2010WO2010073326A1 Percutaneous absorption preparation
07/01/2010WO2010073119A1 Stable pharmaceutical composition containing at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents
07/01/2010WO2010072950A1 Formulation for delivering lipid-lowering drugs by oral transmucosal administration
07/01/2010WO2010072844A1 Implantable devices for treating hiv
07/01/2010WO2010072795A1 Synthesis of polymer conjugates of indolocarbazole compounds
07/01/2010WO2010072421A2 Hydrogel composition for the treatment of dermatological disorders
07/01/2010WO2010072419A2 Enema preparations and their use
07/01/2010WO2010072406A1 Novel transporter constructs and transporter cargo conjugate molecules
07/01/2010WO2010072405A1 Efficient transport into white blood cells
07/01/2010WO2010072353A1 Liquid pharmaceutical compositions comprising a triptan compound and xylitol
07/01/2010WO2010072275A1 Efficient delivery of medicaments into white blood cells
07/01/2010WO2010072228A1 Novel transporter constructs and transporter cargo conjugate molecules
07/01/2010WO2010072109A1 A sustained release system for tumor treating medicament
07/01/2010WO2010072105A1 A enteric formulation of duloxetine and its core and prepration method
07/01/2010WO2010072018A1 Crosslink dextran magnetic complex microparticles and the preparation method and using method thereof
07/01/2010WO2010046933A3 Pharmaceutical compositions of taste-masked linezolid
07/01/2010WO2010045370A3 Method of preparing polyglutamate conjugates
07/01/2010WO2010041279A3 Sustained release drug delivery system
07/01/2010WO2010039496A3 Nanocarriers for drug delivery
07/01/2010WO2010033832A3 Estriol formulations
07/01/2010WO2009135888A3 Complex comprising both heparin binding proteins and heparin-hydroxyalkyl starch conjugates
07/01/2010WO2009106502A3 Implant and method for the manufacture thereof
07/01/2010US20100168381 Conjugates of membrane translocating agents and pharmaceutically active agents
07/01/2010US20100168254 Hydrogel composition for the treatment of dermatological disorders
07/01/2010US20100168252 Sugar derivatives, method for preparation thereof, their use as surface-active agents
07/01/2010US20100168214 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
07/01/2010US20100168187 Therapeutic combination
07/01/2010US20100168044 Superparamagnetic nanoparticle encapsulated with stimuli responsive polymer for drug delivery
07/01/2010US20100167992 Phenyl Ester Side Chains to Increase Polymer Resorptivity
07/01/2010US20100167991 Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
07/01/2010US20100167985 Oral insulin composition and methods of making and using thereof
07/01/2010US20100166875 Colouring composition comprising starch derivatives as a hydrocolloid
07/01/2010US20100166874 Technology for Preparation of Macromolecular Microspheres
07/01/2010US20100166873 Eutectic-Based Self-Nanoemulsified Drug Delivery System
07/01/2010US20100166858 Modified release formulations containing drug-ion exchange resin complexes
07/01/2010US20100166855 Oral insulin composition and methods of making and using thereof
07/01/2010US20100166730 Liquid, Aqueous Pharmaceutical Composition of Factor VII Polypeptides
1 ... 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 ... 1712